ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1678 • 2013 ACR/ARHP Annual Meeting

    How Similar Are Extracranial Giant Cell Arteritis and Takayasu Arteritis?

    Tanaz A. Kermani1, Cynthia S. Crowson2, Francesco Muratore3, Jean Schmidt4, Eric L. Matteson5 and Kenneth J. Warrington6, 1Rheumatology, University of California Los Angeles, Los Angeles, CA, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 3Rheumatology Service, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 4Internal Medicine and RECIF, CHU Nord, Amiens, France, 5Rheumatology, Mayo Clinic, Rochester, MN, 6Division of Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose:   The clinical and radiographic features of giant cell arteritis (GCA) with extracranial (large-vessel) involvement can be similar to those of Takayasu arteritis (TAK)…
  • Abstract Number: 1679 • 2013 ACR/ARHP Annual Meeting

    Clinical Implications Of Antiphospholipid Antibodies In Takayasu’s Arteritis

    Natasha Jordan1, Holy Bezanahary1 and David P. D'Cruz2, 1Louise Coote Lupus Unit, St Thomas' Hospital, London, United Kingdom, 2Louise Coote Lupus Unit, Louise Coote Lupus Unit, St Thomas' Hospital, London, United Kingdom

    Background/Purpose: Takayasu’s arteritis (TA) is a granulomatous inflammation of unknown origin involving the aorta and its major branches. Association and implication of antiphospholipid antibodies (aPL)…
  • Abstract Number: 1680 • 2013 ACR/ARHP Annual Meeting

    Predictivity Of Serum Biomarkers For Disease Activity In a Prospectively Followed-Up Takayasu Arteritis Cohort: Is Serum Amyloid A Protein Better Than Conventional Acute Phase Markers?

    Ahmet Omma1, Burak Erer2, Nilufer Alpay3, Nuray Gurel Polat4, Ahmet Gul1, Murat Inanc4, Lale Ocal1 and Sevil Kamali1, 1Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Department of Internal Medicine, Rheumatology Division, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey, 3Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 4Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

    Background/Purpose: Takayasu arteritis (TA) is a chronic vasculitis with an indolent course. Reliable diagnostic and activity markers have not yet been demonstrated. We aimed to…
  • Abstract Number: 1682 • 2013 ACR/ARHP Annual Meeting

    Patients With TAKAYASU’S Arteritis Having Persistent ACUTE PHASE Response Usually Have An Increased MAJOR Vessel Uptake By 18F-FDG-PET/CT

    Fatma Alibaz-Oner1, Fuat Dede2, Tunc Ones3, H.Turgut Turoglu2 and Haner Direskeneli1, 1Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, 2Nuclear Medicine, Marmara University, School of Medicine, Istanbul, Turkey, 3Nuclear Medicine, Marmara University, School of Medicine, ISTANBUL, Turkey

    Background/Purpose: 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET/CT) is a sensitive imaging tool for large-vessel vasculitis. Although not uniformly accepted, an increased uptake by 18F-FDG PET/CT…
  • Abstract Number: 1683 • 2013 ACR/ARHP Annual Meeting

    High Prevalence Of Metabolic Syndrome In Takayasu Arteritis: An Increased Cardiovascular Risk and Lower Adiponectin Serum Levels

    Thiago Silva1, Mauricio Levy-Neto2, Rosa M. R. Pereira3 and Eloisa Bonfa4, 1Rheumatology Division, University of São Paulo, São Paulo, Brazil, 2Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 3Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Rheumatology Division, Universidade de Sao Paulo, São Paulo, Brazil

    Background/Purpose: The prevalence of Metabolic Syndrome (MetS) tends to be high among rheumatic patients, and cardiovascular disease is the leading cause of death in these…
  • Abstract Number: 1684 • 2013 ACR/ARHP Annual Meeting

    Early Combination Immunosuppression and Serial Non-Invasive Imaging Improves Outcome In Takayasu Arteritis

    Taryn Youngstein1, Michael Quinn1, James Peters1 and Justin C. Mason2, 1Rheumatology Unit, Hammersmith Hospital, Imperial College London, London, United Kingdom, 2Rheumatology and Vascular Sciences, Hammersmith Hospital, Imperial College London, London, United Kingdom

    Background/Purpose: Takayasu arteritis (TA) affects the aorta and its branches, pre-disposing to stenoses and aneurysmal dilatation. While morbidity remains high, evidence for efficacy of immunosuppressive…
  • Abstract Number: 1659 • 2013 ACR/ARHP Annual Meeting

    Systematic Review Of Amyloid Beta-Related Angiitis: A Treatable Cause Of Vasculitis Affecting Central Nervous System

    Abhijeet Danve1 and Atul A. Deodhar2, 1Rheumatology, Oregon Health and Science University, Portland, OR, 2Oregon Health and Science University, Portland, OR

    Background/Purpose: Amyloid β-related angiitis (ABRA) is a rare type of Central Nervous System Vasculitis (CNSV), which complicates Cerebral Amyloid Angiopathy (CAA).  Data about clinical features,…
  • Abstract Number: 1643 • 2013 ACR/ARHP Annual Meeting

    Ex Vivo Suppression Of RA Effector T Cells (Teff) By Mapc Media Is Synergistic With Treg

    Gali Malul1, David Soler2, Donald D. Anthony3, Hillard M. Lazarus4, Nicholas Lehman5, Thomas McCormick2, Julia M. Sugalski6, Anthony E. Ting5 and Nora G. Singer7, 1Rheumatology, MetroHealth Medical Center, Cleveland, OH, 2Dermatology, Case Medical Center, Cleveland, OH, 3Medicine, Case Western Reserve University, Cleveland, OH, 4Comprehensive Cancer Center, Case Medical Center, Cleveland, OH, 5Athersys, Inc., Cleveland, OH, 6Medicine/infectious disease, Case Western Reserve University, Cleveland, OH, 7Medicine, Division of Rheumatology, MetroHealth Medical Center, Cleveland, OH

    Background/Purpose: Use of mesenchymal/multipotent stem cells (MSCs/MAPCs) is an emerging immune modulatory therapeutic strategy promising for a number of human diseases. Multipotent adult progenitor cells…
  • Abstract Number: 1645 • 2013 ACR/ARHP Annual Meeting

    Circulating CD4+CD161+ T Lymphocytes Are Increased In Seropositive Arthralgia Patients But Decreased In Patients With Newly Diagnosed Rheumatoid Arthritis

    Paulina Chalan1, Bart-Jan Kroesen2, Kornelis S.M. van der Geest1, Minke G. Huitema1, Wayel H. Abdulahad3, Elisabeth Brouwer1 and Annemieke M.H. Boots4, 1Dept. of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 2Dept. of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 4Dept. of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Improved understanding of the immune events discriminating between seropositive arthralgia and clinical synovitis is of key importance in rheumatology research. Ample evidence suggests a…
  • Abstract Number: 1646 • 2013 ACR/ARHP Annual Meeting

    Alterations In Circulating T Follicular Helper Cells and T Regulatory Cells In Autoimmune Rheumatic Diseases Treated With B Cell Depletion Therapy: Rituximab

    Pamela M.K Lutalo1,2, Yuan Zhao2, Lee Meng Choong1, Shirish Sangle1, Jo Spencer3 and David P. D'Cruz4, 1Louise Coote Lupus Unit, St Thomas' Hospital, London, United Kingdom, 2Peter Gorer Department of Immunobiology, School of Medicine, King's College London, London, United Kingdom, 3Peter Gorer Department of Immunobiology, King's College London, School of Medicine, London, United Kingdom, 4Louise Coote Lupus Unit, Louise Coote Lupus Unit, St Thomas' Hospital, London, United Kingdom

    Background/Purpose: Granulomatosis with polyangiitis (GPA) and systemic lupus erythematosus (SLE) are autoimmune rheumatic diseases which develop due to failure of immune self-tolerance. T follicular helper…
  • Abstract Number: 1647 • 2013 ACR/ARHP Annual Meeting

    An Altered Frequency Of Circulating Follicullar T Helper Cell Counterparts and Their Subsets Is Associated With Increased Circulating Plasmablasts In Seropositive RA Patients

    Irene Arroyo-Villa1, M. Belén Bautista-Caro1, Alejandro Balsa2, Pilar Aguado2, Alejandro Villalba1, Chamaida Plasencia2, Amaya Puig-Kröger3, Emilio Martín-Mola1 and Maria Eugenia Miranda-Carus1, 1Rheumatology, Hospital La Paz - IdiPaz, Madrid, Spain, 2Rheumatology, Hospital La Paz-IdiPaz, Madrid, Spain, 3Immuno-oncology, Hospital Gregorio Marañon, Madrid, Spain

    Background/Purpose: Follicular T helper (Tfh) cells, a CD4 T helper subset localized in lymphoid organs, help B cell differentiation and function. Circulating CD4 T cells…
  • Abstract Number: 1648 • 2013 ACR/ARHP Annual Meeting

    PD-1+CD45RBlo122lo Autoantibody-Inducing CD4 T Cells (aiCD4 T cells) As a Key In The Pathogenesis Of Systemic Lupus Erythematosus (SLE)

    Yumi Miyazaki1, Ken Tsumiyama2 and Shunichi Shiozawa1, 1Department of Medicine, Kyushu University Beppu Hospital, Beppu, Japan, 2Department of Rheumatology, Kyushu University Beppu Hospital, Beppu, Japan

    Background/Purpose:  We found that systemic lupus erythematosus (SLE) was induced experimentally by repeatedly immunizing the mice normally not prone to autoimmune diseases by any exogenous…
  • Abstract Number: 1649 • 2013 ACR/ARHP Annual Meeting

    Assessment Of Cytomegalovirus-Specific T Cell Responses Upon Initiation Of Immunosuppression In Patients Suffering From Rheumatic Diseases As Novel Approach For Functional Immune Monitoring

    Emmanuelle Le Bras1,2, Sandra Weigand3, Ludwig Deml4, Dagmar Halbritter5, Boris P. Ehrenstein3, Wolfgang Hartung3 and Martin Fleck2,3, 1Rheumatology & Clinical Immunology, Asklepios Clinic Bad Abbach, 93077 Bad Abbach, Germany, 2Internal Medicine I, University Medical Center of Regensburg, Regensburg 93053, Germany, 3Rheumatology & Clinical Immunology, Asklepios Clinic Bad Abbach, Bad Abbach, Germany, 4research director, Lophius Biosciences GmbH, Regensburg 93053, Germany, 5Internal Medicine I, University Medical Center of Regensburg, 93042 Regensburg, Germany

    Background/Purpose: The management of immunosuppressive therapies is challenging, as physicians are confronted with difficulties to keep the balance between immunosuppression on one hand and raised…
  • Abstract Number: 1650 • 2013 ACR/ARHP Annual Meeting

    The Route Of T Cell Priming Determines The Requirement For IL-23 In The Development Of Arthritis

    Alison Finnegan1, Yanxia Cao1 and Susan Olalekan2, 1Dept of Medicine, Rush University Medical Center, Chicago, IL, 2Immunology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Rheumatoid arthritis is a very heterogeneous disease and distinct molecular mechanisms may underlie the disease process.  IL-23 is an important cytokine for the expansion…
  • Abstract Number: 1652 • 2013 ACR/ARHP Annual Meeting

    Autophagy May Contribute To Glucocorticoid Resistance In Patients With Myositis By Maintaining T Lymphocytes Homeostasis In The Muscles

    Mei Zong1, John Jörholt2, Julia Winter2, Eva Lindroos3, Helena E. Harris2 and Ingrid E. Lundberg4, 1Rheumatology Unit, Department of Medicine, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, 2Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden, 3Department of Medicine, Rheumatology Unit, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden., Stockholm, Sweden, 4Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Infiltrating T cells is a typical histopathologic feature in muscles of patients with myositis and these cells are also believed to play important roles…
  • « Previous Page
  • 1
  • …
  • 2138
  • 2139
  • 2140
  • 2141
  • 2142
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology